A Dubai baby suffering around 110 epileptic seizures a day became seizure-free after an experimental treatment stopped the episodes within 30 minutes. WAM reports that seven earlier treatments had failed. The result is remarkable, but the medicine is still experimental and its wider effectiveness remains unproven.

The details

A baby in Dubai who suffered approximately 110 epileptic seizures every day has shown a remarkable response to an experimental treatment provided through a special medical access programme.

The child, Adnan, has an extremely rare genetic form of epilepsy that caused severe seizures beginning shortly after birth.

Seven earlier treatments had failed to control his condition adequately.

Specialists at King's College Hospital London Dubai used advanced genetic testing to identify the underlying cause and explore a treatment directed at the mechanism involved.

Working with the Emirates Drug Establishment and Dubai Health Authority, the hospital obtained permission to provide an experimental medicine called ABS-1230.

Adnan received his first dose on 14 September 2026. According to his medical team, the seizures stopped within 30 minutes.

He was discharged on 21 September, and follow-up assessments through 11 October recorded no clinical seizures. The hospital subsequently reported that he continued to remain seizure-free.

Doctors say he is the youngest patient worldwide to receive the medication.

The drug remains under investigation and has not been commercially approved. Specialists caution that one patient's response cannot establish its effectiveness or safety for others.